SEARCH

SEARCH BY CITATION

References

  • Aggarwal S. & Pittenger M.F. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 18151822.
  • Arroyo A.G., Yang J.T., Rayburn H. & Hynes R.O. (1999) Alpha4 integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity 11, 555566.
  • Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A. & Hoffman R. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology 30, 4248.
  • Bensidhoum M., Chapel A., Francois S., Demarquay C., Mazurier C., Fouillard L., Bouchet S., Bertho J.M., Gourmelon P., Aigueperse J., Charbord P., Gorin N.C., Thierry D. & Lopez M. (2004) Homing of in vitro expanded Stro-1- or Stro-1 +  human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 103, 33133319.
  • Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E. & Rachmilewitz J. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 22142219.
  • Bol S.J., Tucker D.P. & Ekert H. (1990) Selection of two human bone marrow stromal cell subpopulations with different effects on the maintenance and differentiation of myeloid progenitor cells. Experimental Hematology 18, 764769.
  • Brouard N., Chapel A., Thierry D., Charbord P. & Peault B. (2000) Transplantation of gene-modified human bone marrow stromal cells into mouse-human bone chimeras. Journal of Hematotherapy and Stem Cell Research 9, 175181.
  • Castro-Malaspina H., Gay R.E., Resnick G., Kapoor N., Meyers P., Chiarieri D., McKenzie S., Broxmeyer H.E. & Moore M.A. (1980) Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56, 289301.
  • Coyne T.M., Marcus A.J., Woodbury D. & Black I.B. (2006) Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 24, 24832492.
  • Dennis J.E., Carbillet J.P., Caplan A.I. & Charbord P. (2002) The STRO-1 +  marrow cell population is multipotential. Cells Tissues Organs 170, 7382.
  • Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S. & Gianni A.M. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 38383843.
  • Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noel D. & Jorgensen C. (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 38373844.
  • Eliopoulos N., Stagg J., Lejeune L., Pommey S. & Galipeau J. (2005) Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106, 40574065.
  • Francois S., Bensidhoum M., Mouiseddine M., Mazurier C., Allenet B., Semont A., Frick J., Sache A., Bouchet S., Thierry D., Gourmelon P., Gorin N.C. & Chapel A. (2006) Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24, 10201029.
  • Friedenstein A.J., Chailakhjan R.K. & Lalykina K.S. (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetica 3, 393403.
  • Grinnemo K.H., Mansson A., Dellgren G., Klingberg D., Wardell E., Drvota V., Tammik C., Holgersson J., Ringden O., Sylven C. & Le Blanc K. (2004) Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. Journal of Thoracic and Cardiovascular Surgery 127, 12931300.
  • Gronthos S., Zannettino A.C., Hay S.J., Shi S., Graves S.E., Kortesidis A. & Simmons P.J. (2003) Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. Journal of Cell Science 116, 18271835.
  • Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D. & Mao N. (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105, 41204126.
  • Jones E.A., English A., Kinsey S.E., Straszynski L., Emery P., Ponchel F. & McGonagle D. (2006) Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry. Part B, Clinical Cytometry 70, 391399.
  • Kenneth J.L. & Thomas D.S. (2001) Analysis of relative gene expression data using relative time quantitative PCR and 2DDCt. Methods 25, 402408.
  • Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E. & Dazzi F. (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 37223729.
  • Lazarus H.M., Koc O.N., Devine S.M., Curtin P., Maziarz R.T., Holland H.K., Shpall E.J., McCarthy P., Atkinson K., Cooper B.W., Gerson S.L., Laughlin M.J., Loberiza F.R. Jr, Moseley A.B. & Bacigalupo A. (2005) Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biology of Blood and Marrow Transplantation 11, 389398.
  • Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E. & Ringden O. (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian Journal of Immunology 57, 1120.
  • Le Blanc K., Rasmusson I., Gotherstrom C., Seidel C., Sundberg B., Sundin M., Rosendahl K., Tammik C. & Ringden O. (2004a) Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scandinavian Journal of Immunology 60, 307315.
  • Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M. & Ringden O. (2004b) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 14391441.
  • Letchford J., Cardwell A.M., Stewart K., Coogans K.K., Cox J.P., Lee M., Beresford J.N., Perry M.J. & Welham M.J. (2006) Isolation of C15: a novel antibody generated by phage display against mesenchymal stem cell-enriched fractions of adult human marrow. Journal of Immunological Methods 308, 124137.
  • Maccario R., Podesta M., Moretta A., Cometa A., Comoli P., Montagna D., Daudt L., Ibatici A., Piaggio G., Pozzi S., Frassoni F. & Locatelli F. (2005) Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4 +  T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90, 516525.
  • Maitra B., Szekely E., Gjini K., Laughlin M.J., Dennis J., Haynesworth S.E. & Koc O.N. (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplantation 33, 597604.
  • Meisel R., Zibert A., Laryea M., Gobel U., Daubener W. & Dilloo D. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103, 46194621.
  • Nasef A., Chapel A., Mazurier C., Bouchet S., Lopez M., Mathieu N., Sensebé L., Zhang Y., Gorin N., Thierry D. & Fouillard L. (2007) Identification of IL-10 and TGF-b transcripts involved in inhibiting T Lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expression 13, 217226.
  • Potian J.A., Aviv H., Ponzio N.M., Harrison J.S. & Rameshwar P. (2003) Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. Journal of Immunology 171, 34263434.
  • Roth I., Corry D.B., Locksley R.M., Abrams J.S., Litton M.J. & Fisher S.J. (1996) Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. Journal of Experimental Medicine 184, 539548.
  • Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J. & Carosella E.D. (1997) Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proceedings of the National Academy of Sciences of the United States of America 94, 1152011525.
  • Simmons P.J. & Torok-Storb B. (1991) Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 5562.
  • Steckel N.K., Kuhn U., Beelen D.W. & Elmaagacli A.H. (2003) Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance? Scandinavian Journal of Immunology 57, 185191.
  • Stewart K., Monk P., Walsh S., Jefferiss C.M., Letchford J. & Beresford J.N. (2003) STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell and Tissue Research 313, 281290.
  • Tondreau T., Lagneaux L., Dejeneffe M., Delforge A., Massy M., Mortier C. & Bron D. (2004) Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy 6, 372379.
  • Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C. & Guinan E.C. (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389397.
  • Verfaillie C.M. (1998) Adhesion receptors as regulators of the hematopoietic process. Blood 92, 26092612.
  • Zhang W., Ge W., Li C., You S., Liao L., Han Q., Deng W. & Zhao R.C. (2004) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells and Development 13, 263271.